CHEMICAL Company of Malaysia Bhd (CCM) has emerged as a more nimble entity barely a year after its demerger with its former largest earnings contributor and 73.4%-owned subsidiary, CCM Duopharma Biotech Bhd (CCMD), which also continues to do well.
CCMs net profit for the nine months ended Sept 30 (9MFY2018), was 25% lower year on year, without the RM21.14 million contribution from CCMD.
Nonetheless, CCMs profit attributable to shareholders from its continuing operations for 9MFY2018 jumped tenfold to RM17.07 million. This was helped by improved sales and margins and a positive impact from operational efficiency initiatives, according to the notes accompanying its accounts. CCM, which is making strong efforts to expand the core businesses…
Read the full article at: http://www.theedgemarkets.com/article/best-corporate-restructuring-unleashing-potential-ccm-and-ccmd